Articles tagged with Bound Proteins
Researchers have found a way to control MYC's hyperactivity using a peptide compound with sub-micro-molar affinity. This breakthrough offers hope for more effective treatments for cancer patients.
Scientists at the University of Washington School of Medicine developed a novel protein design approach using AI, creating proteins that bind to challenging biomarkers with exceptionally high affinity and specificity. The breakthrough has implications for drug development, disease diagnosis, and environmental monitoring.
Scientists discovered that a bacterial defense system can induce self-destruction when bound to specific proteins, marking a new phenomenon in enzymatic function. This switch allows the bacteria to eliminate a vital molecule needed for survival, ultimately leading to their demise.
Researchers discovered NSMF protein's role in alleviating DNA replication stress by displacing weakly bound RPA proteins and promoting phosphorylation. This mechanism accelerates relief of replication stress, offering a new direction for treating various diseases, including cancer and age-related conditions.
Scientists have discovered that SARS-CoV-2 can infect cells using multiple entry points beyond ACE2, explaining its ability to jump between species. This finding highlights the need for continued monitoring of coronaviruses and their potential to cause future pandemics.
Researchers have revealed key atomic structures of actin filament ends using cryo-electron microscopy. The study provides fundamental insights into the mechanism behind actin filament polarity, shedding light on disorders such as muscle weakness and heart problems.
Dr. John H. Bushweller's team at UVA Cancer Center is developing novel drugs to block abnormal proteins that cause pediatric leukemia. The new approach aims to improve efficacy and reduce toxicity, potentially leading to better patient outcomes.
Researchers have identified a common amino acid, glycine, as a potential trigger for major depression, anxiety, and other mood disorders. The discovery improves understanding of the biological causes of major depression and could accelerate efforts to develop new medications.
Researchers used C-trap technology to investigate how different DNA repair proteins identify and bind to their respective forms of damage. They found that some proteins arrived at the damage site together and departed together, while others showed surprising variability in their association and dissociation patterns. The study provides...
A new study uses serial femtosecond X-ray crystallography to reveal the structure of NendoU protein at room temperature. The resulting high-resolution image shows that the protein's flexibility plays a crucial role in its functional mechanism, which is essential for designing antiviral drugs against SARS-CoV-2.
A new study reveals that HOXA5 binds to protein IκB-α, boosting its cancer-suppressing properties and reducing the development of breast cancers. The presence of HOXA5 suppresses malignancy in breast epithelial cells by blunting NF-κB action.
Scientists at KAUST have identified dynamic regions, called cryptic binding sites, that can be targeted by drugs to treat cancer. The study reveals how molecular motion influences ligand binding to BTB domains, a critical part of many proteins involved in disease.
The Rutgers team developed an analytical toolkit to measure protein-carbohydrate interactions with single-molecule precision. By adjusting the 'stickiness' of enzymes, they aim to enhance cellulose decomposition for biofuels production and improve healthcare targeting protein-based drugs.
Researchers developed an AI-based screening method that models drug and target protein interactions using natural language processing techniques. The technique achieved high accuracy in identifying promising drug candidates, which can accelerate the exploration of new medicines and repurpose existing ones.
A new study reveals that the emergence of a new gene called PGBD1 is linked to the evolution of a new structure in nerve cells. PGBD1 controls paraspeckles, tiny structures that act like traps for RNAs and proteins, and its regulation is crucial for nerve cell development.
Researchers at Texas A&M University are developing mathematical models to predict and control cellular differentiation. They created a technique using mix-and-read assays, which allow for the detection of key signaling proteins in live tissues. This method enables researchers to gain a deeper understanding of how cells make decisions.
A new study by the University of Colorado Anschutz Medical Campus explores the effects of multiple mutations in SARS-CoV-2 variants. The findings suggest that certain mutations work together to improve virus fitness, making it challenging for antibody treatments to neutralize new variants.
A team of scientists created a powerful new method for generating protein drugs by designing molecules that can target important proteins in the body. The research yielded candidate medicines for cancer, diabetes, infection, inflammation, and beyond, offering a paradigm shift in drug development.
Scientists at MIT have developed a screening method to study protein-protein interactions, which are crucial in understanding disease mechanisms. The researchers created a synthetic molecule that binds tightly to a protein implicated in cancer metastasis, providing a potential tool for disrupting disease-causing interactions.
Researchers developed a novel polymeric nanoparticle that selectively binds to fibrinogen in human plasma, offering a simpler and less expensive way to manufacture fibrinogen concentrate. This breakthrough could lead to the creation of more efficient fibrinogen-specific affinity reagents for drug development.
A new computational tool allows precise prediction of protein interfaces for COVID-19 and human interactions. This breakthrough enables researchers to better understand virus development, identify high-risk populations, and develop targeted drugs.
Researchers have developed a neural network model called BiteNetPp to detect protein-peptide binding sites, enabling the design of peptide-based drugs. The model consistently outperforms existing methods and can analyze a single protein structure in under a second, making it suitable for large-scale studies.
Researchers at the University of Cincinnati found that a protein in skeletal muscle fibers regulates the body's fight or flight response, enabling quick bursts of power. This discovery may lead to advancements in understanding and addressing skeletal muscular disorders.
Researchers have made detailed images of coronavirus spike proteins in their natural state using cryo-EM and computation. The study provides crucial insights into how the virus initiates infections and sheds light on sugar molecule attachments that play a critical role in its life cycle.
A team of researchers from UC Santa Barbara and LMU found that enzymes can cause liquid droplets formed from DNA to bubble unexpectedly. The bubbles occur when the enzyme penetrates inside the droplet, leading to an osmotic effect that causes water to be drawn in, resulting in a swelling phenomenon.
Researchers discovered that DNA droplets can exhibit bubbling behavior, similar to boiling water, when exposed to certain enzymes. This phenomenon occurs in lightly-bound systems, where the enzyme penetrates the crowded DNA particles, causing an osmotic effect and leading to a burping-like outburst.
Researchers discovered that proteins use the DNA's three-dimensional structure as a type of keyhole to select specific binding sites, rather than just patterns in the genome's code. Over 80% of proteins bind to a specific shape pattern in the genome, which helps explain how they avoid confusing different sequences.
Researchers at ETH Zurich have developed a new screening method that speeds up the search for drugs using a 35 million compound DNA-encoded chemical library. The library consists of drug candidates with a stable ring-shaped basic structure and varied attachments, allowing for highly-specific binding to proteins.
A Northwestern University study found that free-floating proteins can break up protein-DNA bonds at a single-binding site, disrupting gene expression. This discovery challenges previous beliefs about the stability of protein-DNA interactions and has implications for understanding biological processes in living cells.
Scientists at Umeå University discovered a protein interaction that slows down a key chemical reaction in the bacteria Yersinia pseudotuberculosis. This finding opens up new avenues for studying the regulation of bacterial virulence, which can help develop new treatments for infections.
Researchers developed a novel super-resolution imaging method to monitor dynamic protein binding, such as talin and vinculin, in living cells. The study revealed clustered binding of vinculins to talin, with five or more molecules binding in one second.
Researchers at Osaka University have clarified the involvement of AGT1 in renal reabsorption of cystine. They found that complexes of AGT1 and rBAT transport cystine and acidic amino acids, identifying a second cystine transporter in proximal tubules.
DeepBind uses deep learning to analyze protein-DNA/RNA binding and detect mutations that can disrupt cellular processes. The tool provides new information on disruptions in mutations tied to cancers, haemophilia, and familial hypercholesterolemia.
Researchers identified proteinaceous binding media used in polychrome layers of Qin Shihuang's terracotta army. Natural pigments and binding media were found to be composed of cinnabar, apatite, azurite, and malachite.
Case Western Reserve University researchers discover that non-specific RNA binding proteins can be specific about where they bind to RNA molecules, seeking out particular sequences. This finding advances understanding of how proteins control gene expression and sheds light on diseases such as cancer and neurodegenerative disorders.
Researchers found a new switch involved in dosage compensation, which doubles gene activity on the male X chromosome. This switch, revealed to be a hairpin structure, must be unwound by an enzyme before MSL proteins can bind, allowing for functional assembly of the Dosage Compensation Complex.
A recent study found that low serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) are associated with Alzheimer's disease in men, but not women. IGF-1 may be a potential treatment target for early-stage Alzheimer's disease.
Researchers investigate protein binding mechanisms, including the recently discovered fly-casting method, which accelerates binding by unfolding a protein chain. Temperature influences capture radius, with optimal conditions found at transition temperatures between folding and unfolding.
A team of scientists discovered a molecule that can prevent a toxic protein involved in Alzheimer's disease from building up in the brain. Using fruit flies engineered to develop a fly equivalent of Alzheimer's disease, they showed that the same molecule effectively cures the insects of the disease.
Scientists create a protein that selectively binds to uranium, offering potential methods for detecting and treating uranium poisoning. The protein is based on a nickel-binding protein from E. coli and has been engineered to bind to uranium instead.
Scientists have discovered a 3D structure of an NS1 protein that suppresses human defenses against the flu virus, paving the way for new drug development. The breakthrough could lead to effective treatments for avian influenza and other human strains.
Researchers developed a new method to identify linear motifs in protein sequences, which interact with other molecules. The technique uses large-scale studies of protein binding and computer analysis to predict motif patterns.
Researchers at UCLA and NIH have discovered a new compound that can block viruses from entering cells, providing potential relief for conditions like HIV, herpes, and the flu. The compound also shows promise in combating antibiotic-resistant bacteria.
Researchers found that human p53 and Cep-1, a roundworm protein, bind to similar DNA sequences in their respective genomes but in different conformations. The study suggests that both proteins exist primarily as tetramers under normal circumstances, leading to a new understanding of how they interact with DNA.
Researchers discovered the YB-1 protein's Cold Shock domain, resembling a bucket with handle and two ears, attaches DNA to its binding site. The domain alone forms weak bonds to DNA, contradicting previous measurements of complete protein strength.
The structure of MEF2 protein reveals key to its function in regulating genes across various cell types, including muscle, brain, and immune cells. By altering the protein's binding groove, researchers may uncover new targets for therapeutic strategies.
Researchers at the University of Washington have developed a coating process that attracts and binds specific proteins to biomaterial surfaces, promoting affinity for natural healing. The technique, which uses keyhole-like indentations and sugar molecules, has shown strong affinity for proteins in laboratory experiments.
A Weizmann Institute study suggests that master-key antibodies interact with proline on proteins and protein fragments to escort them out of the body. This research provides scientific basis for theory that these antibodies may remove broad range of unneeded proteins without affecting beneficial ones.
Researchers at Cornell University have successfully determined the structure of a newly identified key protein, expanding our understanding of cellular function and potential therapeutic targets. The discovery opens doors to further investigation of this protein's role in various diseases.